People taking medical cannabis for chronic pain have a slightly increased risk of arrhythmia, according to research published in the European Heart Journal today (Thursday). Arrhythmia is when the heart beats too slowly, ...
Jan 10, 2024
0
18
Researchers have studied the association of proprotein convertase subtilisin/kexin type 9 (PCSK9) with soluble P-selectin (sP-selectin) and their values in predicting major adverse cardiovascular events (MACE) at one-year ...
Jan 8, 2024
0
0
In a guideline update issued by the Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology and published online Oct. 28 in the Canadian Journal of Cardiology, new recommendations are presented regarding ...
Dec 23, 2023
0
0
A new review article, published in Cardiovascular Innovations and Applications offers solutions to improve access to underutilized cardiac rehabilitation.
Nov 24, 2023
0
0
Young patients from the Middle East and Gulf region presenting with acute coronary syndrome have a greater prevalence of risk factors, including smoking and high cholesterol compared to older patients also presenting with ...
Nov 1, 2023
0
0
For patients with acute coronary syndrome (ACS), stopping dual antiplatelet therapy (DAPT) within one month for ticagrelor monotherapy is noninferior and superior to 12 months of ticagrelor-based DAPT, according to a study ...
Oct 27, 2023
0
0
The health care landscape has undergone rapid changes in recent years, requiring clinicians and stakeholders to consider innovative ways to provide care in traditional and non-traditional settings. The American College of ...
Sep 26, 2023
0
1
Patients who have suffered a heart attack should immediately be offered a combination of cholesterol lowering drugs with statins and ezetimibe, according to research published in the Journal of the American Heart Association.
Sep 6, 2023
0
8
Inorganic nitrate reduces contrast-induced nephropathy (CIN), improves renal outcomes and reduces cardiac events compared to placebo in patients at risk of renal injury undergoing coronary angiography for acute coronary syndrome, ...
Aug 29, 2023
0
1
Extended P2Y12 inhibitor monotherapy beyond 12 months after percutaneous coronary intervention (PCI) reduces bleeding and ischemic events in acute coronary syndrome (ACS) patients at high risk for both types of events. That's ...
Aug 28, 2023
0
28
